Search - tctmd.com

Displaying 41 - 60 of 239

Sort: Relevancy | Date

Presentation TCT 2024

TCT 675: Assessment of Coronary Microvascular Dysfunction in Patients With Diabetes Mellitus Presenting With Angina With Nonobstructive Coronary Arteries

Presenter: Sant Kumar

October 27, 2024

Presentation TCT 2024

TCT 677: Evaluating Ischemia With Nonobstructive Coronary Arteries Using Invasive Coronary Function Testing: Insights From the DISCOVER INOCA Multicenter Registry

Presenter: Samit Shah

October 27, 2024

Presentation TCT 2024

TCT 679: Coronary Microvascular Dysfunction in Patients With Cancer Experiencing Angina With Nonobstructive Coronary Arteries

Presenter: Abhishek Chaturvedi

October 27, 2024

News Conference News EACTS 2024

Enhanced Recovery After Cardiac Surgery: Fewer Complications, Shorter Stays

Yael L. Maxwell

October 16, 2024

News Conference News HFSA 2024

‘Global Efficacy’ of Aficamten for Obstructive Disease Shown in SEQUOIA-HCM

L.A. McKeown

October 02, 2024

News Daily News

Debating a PCI-First Strategy in Stable CAD: ORBITA-2 vs the Unconvinced

Michael O'Riordan

September 20, 2024

News Conference News ESC 2024

ESC’s 2024 CCS Guidelines Embrace New Data, Smooth Old Tensions

Michael O'Riordan

September 17, 2024

News Daily News

CMR Could Change Diagnosis, Management of Suspected NSTEMI: OxAMI

Yael L. Maxwell

July 18, 2024

News Daily News

Temperature Highs and Lows Leave Their Mark on CV Deaths

L.A. McKeown

June 03, 2024

News Daily News

AI-Assisted Look at Coronary Inflammation on CT Refines CV Risk Assessment

Todd Neale

May 31, 2024

News Daily News

With ANOCA, Better to Test Coronary Function in Multiple Vessels

Caitlin E. Cox

May 29, 2024

News Conference News EuroPCR 2024

Go Beyond Angiography in CCS to Pinpoint the Problem, Urges AID-ANGIO

Caitlin E. Cox

May 14, 2024

News Daily News

New HCM Guidelines Focus on Cardiac Myosin Inhibitors and Exercise

Yael L. Maxwell

May 08, 2024

News Daily News

INOCA May Be at the Root of Angina for Many Long-COVID Patients

Caitlin E. Cox

April 17, 2024

News Conference News ACC 2024

IMPROVE-HCM: Ninerafaxstat May Fill a Niche in Nonobstructive HCM

Caitlin E. Cox

April 15, 2024

Presentation ACC 2024

Efficacy and Safety of Ninerafaxstat, a Novel Cardiac Mitotrope, in Patients with Symptomatic Nonobstructive Hypertrophic Cardiomyopathy (Results of IMPROVE-HCM)

Presenter: Martin S. Maron

April 08, 2024

News Opinion CV Team Dispatch

April 2024 Dispatch for the CV Team

L.A. McKeown

April 01, 2024

News Opinion Editor's Corner ACC 2024

What’s Going to Be Hot at ACC 2024

Shelley Wood

April 01, 2024

Presentation THT 2024

Cardiac Myosin Inhibitors as a Novel Treatment Option for Nonobstructive Hypertrophic Cardiomyopathy

Presenter: Ahmad Masri

March 04, 2024

Presentation Miami Valves 2024

Intracoronary Physiology and its Role in Ischemia with Nonobstructive Coronary Arteries (INOCA)

Presenter: Fatima Lakhani

February 01, 2024

Advertisement

TCT 675: Assessment of Coronary Microvascular Dysfunction in Patients With Diabetes Mellitus Presenting With Angina With Nonobstructive Coronary Arteries

TCT 677: Evaluating Ischemia With Nonobstructive Coronary Arteries Using Invasive Coronary Function Testing: Insights From the DISCOVER INOCA Multicenter Registry

TCT 679: Coronary Microvascular Dysfunction in Patients With Cancer Experiencing Angina With Nonobstructive Coronary Arteries

Enhanced Recovery After Cardiac Surgery: Fewer Complications, Shorter Stays

‘Global Efficacy’ of Aficamten for Obstructive Disease Shown in SEQUOIA-HCM

Debating a PCI-First Strategy in Stable CAD: ORBITA-2 vs the Unconvinced

ESC’s 2024 CCS Guidelines Embrace New Data, Smooth Old Tensions

CMR Could Change Diagnosis, Management of Suspected NSTEMI: OxAMI

Temperature Highs and Lows Leave Their Mark on CV Deaths

AI-Assisted Look at Coronary Inflammation on CT Refines CV Risk Assessment

With ANOCA, Better to Test Coronary Function in Multiple Vessels

Go Beyond Angiography in CCS to Pinpoint the Problem, Urges AID-ANGIO

New HCM Guidelines Focus on Cardiac Myosin Inhibitors and Exercise

INOCA May Be at the Root of Angina for Many Long-COVID Patients

IMPROVE-HCM: Ninerafaxstat May Fill a Niche in Nonobstructive HCM

Efficacy and Safety of Ninerafaxstat, a Novel Cardiac Mitotrope, in Patients with Symptomatic Nonobstructive Hypertrophic Cardiomyopathy (Results of IMPROVE-HCM)

April 2024 Dispatch for the CV Team

What’s Going to Be Hot at ACC 2024

Cardiac Myosin Inhibitors as a Novel Treatment Option for Nonobstructive Hypertrophic Cardiomyopathy

Intracoronary Physiology and its Role in Ischemia with Nonobstructive Coronary Arteries (INOCA)

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content